Neuren Pharmaceuticals Limited (ASX:NEU)
Australia
· Delayed Price · Currency is AUD 19.75
+0.67 (3.51%)
At close: Dec 5, 2025
Neuren Pharmaceuticals Market Cap
Neuren Pharmaceuticals has a market cap or net worth of 2.50 billion as of December 5, 2025. Its market cap has increased by 54.38% in one year.
Market Cap
2.50B
Enterprise Value
2.20B
Revenue
218.86M
Ranking
n/a
PE Ratio
17.21
Stock Price
19.75
Market Cap Chart
Since February 3, 2005, Neuren Pharmaceuticals's market cap has increased from 20.93M to 2.50B, an increase of 11,837.78%. That is a compound annual growth rate of 25.78%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CSL Limited | 89.61B |
| Pro Medicus | 26.31B |
| Cochlear | 17.81B |
| Sonic Healthcare | 11.39B |
| Ramsay Health Care | 8.54B |
| Ansell | 5.20B |
| Telix Pharmaceuticals | 4.93B |
| Mesoblast | 3.26B |